Weigh the Risks and Benefits to Decipher Med Safety in Pregnancy
October 2018
Patients rely on you for the bottom line on med safety in pregnancy.
The U.S. FDA's older pregnancy letter categories...A, B, C, D, and X...are going by the wayside. They were criticized as being oversimplified and often misinterpreted.
Canadian product labelling summarizes med risk in pregnancy...and in some cases describes human or animal data.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive